Premier Biomedical Inc

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div Yield, %

—

Shrs. gr., 5y

10.29%

Rev. gr., 5y

-37.00%

Revenues

Net income

-87k

L-11.53%

CFO

-171k

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Premier Biomedical, Inc. functions as a company primarily focused on research, actively involved in both the genesis and identification of innovative medical offerings. The firm specifically directs its efforts toward formulating and disseminating topical pain management solutions that incorporate hemp oil. Established by Mitchell S. Felder on May 10, 2010, the company's central operations are based in Knoxville, Tennessee.

URL

https://www.premierbiomedical.com/

IPO date

Feb 23, 2012

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT